Industry reports
Editor highlights

Publication dates

data types

Cystic Fibrosis Market and Forecasts, April 2014

You might be interested in: health insurance, medicine, chromosome, more »


 
1-10 of about 100 reports for Cystic Fibrosis

The Future of Cystic Fibrosis

  • Industry report
  • January 2014
  • 6 pages

... Markets 2019: industry size, shares, growth, trends and forecast 2019" to its huge collection of research reports. View full report at ...

U.S. Autism Industry (autism, cystic fibrosis)

  • Industry report
  • February 2012
  • 14 pages

... While mental retardation, down syndrome and cystic fibrosis remain relatively the same. A january 2009 uc mind institute study refutes this notion. 9.While the cause of autism remains unclear, current ...

U.S. Pharmaceutical Industry

  • Industry report
  • January 2013
  • 38 pages

... To expand existing market > cystic fibrosis drug market $1.2B+ > breakthrough therapy kalydeco targets only 4% of cf population. Sales of $360m. Asthma copd rhinitis other 8 ...

Pharmaceutical Market Overview

  • Industry report
  • August 2012
  • 21 pages
  • by Corporation

... Newly discovered therapeutic roles indication status aatd launched bronchiectasis [phase ii ] cystic fibrosis [phase ii ] type-1 diabetes [phase ii ] copd [pre-clinical] transplant rejection [pre ...

Pharmaceutical Sector in The United States and Israel

  • Industry report
  • June 2012
  • 19 pages
  • by Corporation

... Amp; newly discovered therapeutic roles indication status aatd launched bronchiectasis [phase ii ] cystic fibrosis [phase ii ] type-1 diabetes [phase ii ] copd [pre-clinical] transplant rejection [pre ...

Breast Cancer Sector in The United States

  • Industry report
  • June 2012
  • 18 pages
  • by Governmental Agency

... Old age d. Lung ca 79 basal cell bladder ca d. 45 Breast ca breast ca dx. 39 4 76 Breast ca dx. 46 Unilateral 32 2 21 1 2 3 1 45 36 11 cystic fibrosis 2.5 cystic fibrosis 9 key male female ...

Pharmaceutical Sector in The United States

  • Industry report
  • May 2012
  • 28 pages

... Distress syndrome in premature infants gaucher disease methotrexate toxicity cystic fibrosis g551d mutation 2011 organ rejection, kidney transplant hodgkins lymphoma hereditary angioedema acute ...

The New Zealander Pharmaceutical Industry Brief

  • Industry report
  • September 2012
  • 26 pages

... Hypercholesterolaemia hyperlipidaemia infertility parkinson S depression cystic fibrosis chronic hepatitis b coronary artery disease cerebrovascular disease congestive heart failure disease with deferred ...

The Australian Pharmaceutical Industry Brief

  • Industry report
  • June 2012
  • 16 pages

... Colocare colorectal cancer screening: enterix renal failure/kidney damage: nephrodynamics, osprey testosterone deficiency: acrux arthritis: pargenex osteoporosis: teeleostin cystic fibrosis ...

Pharmaceutical Industry

  • Industry report
  • September 2013
  • 13 pages

... Smoker high blood pressure high cholesterol obesity smoke/drink excessively diabetes asthma coronary artery disease cancer multiple sclerosis cystic fibrosis diabetes asthma coronary ...

» Purchase Premium Reports (From $ 90 - $ 5 995)

59 reports for Cystic Fibrosis
Aradigm Corporation (ARDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aradigm Corporation (ARDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

Summary Aradigm Corporation (Aradigm) is a specialty pharmaceutical company that carries out the development and commercialization of inhalation drugs for the prevention and treatment of severe respiratory ...


» Read our Company Profiles

1 Companies for Cystic Fibrosis

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.